Geneos Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $728K | Sell |
|
|||||
|
2025
Q2 | $618K | Sell |
|
|||||
|
2025
Q1 | $1.07M | Buy |
|
|||||
|
2024
Q4 | $510K | Sell |
|
|||||
|
2024
Q3 | $766K | Sell |
|
|||||
|
2024
Q2 | $765K | Buy |
|
|||||
|
2024
Q1 | $663K | Sell |
|
|||||
|
2023
Q4 | $492K | Sell |
|
|||||
|
2023
Q3 | $511K | Sell |
|
|||||
|
2023
Q2 | $386K | Buy |
|
|||||
|
2023
Q1 | $452K | Sell |
|
|||||
|
2022
Q4 | $470K | Sell |
|
|||||
|
2022
Q3 | $441K | Sell |
|
|||||
|
2022
Q2 | $519K | Sell |
|
|||||
|
2022
Q1 | $675K | Buy |
|
|||||
|
2021
Q4 | $488K | Buy |
|
|||||
|
2021
Q3 | $531K | Sell |
|
|||||
|
2021
Q2 | $546K | Sell |
|
|||||
|
2021
Q1 | $652K | Sell |
|
|||||
|
2020
Q4 | $639K | Buy |
|
|||||
|
2020
Q3 | $409K | Sell |
|
|||||
|
2020
Q2 | $677K | Buy |
|
|||||
|
2020
Q1 | $347K | Buy |
|
|||||
|
2019
Q4 | $369K | Buy |
|
|||||
|
2019
Q3 | $239K | Sell |
|
|||||
|
2019
Q2 | $321K | Buy |
|
|||||
|
2019
Q1 | $525K | Buy |
|
|||||
|
2018
Q4 | $515K | Sell |
|
|||||
|
2018
Q3 | $749K | Buy |
|
|||||
|
2018
Q2 | $289K | Sell |
|
|||||
|
2018
Q1 | $373K | Sell |
|
|||||
|
2017
Q4 | $740K | Sell |
|
|||||
|
2017
Q3 | $706K | Sell |
|
|||||
|
2017
Q2 | $1.37M | Buy |
|
|||||
|
2017
Q1 | $942K | Buy |
|
|||||
|
2016
Q4 | $940K | Buy |
|
|||||
|
2016
Q3 | $315K | Buy |
|
|||||
|
2016
Q2 | $326K | Sell |
|
|||||
|
2016
Q1 | $370K | Buy |
|